Opexa Therapeutics (OPXA)

Recent filings

Opexa Therapeutics Just Received a Notice of Effectiveness - Nov. 21, 2017

Opexa: Unaudited Condensed Consolidated Balance Sheet And Statement Of Income Of Private Acer For The Nine Months Ended September 30, 2017 Blueprint - Nov. 14, 2017

Post-Effective amendments for registration statement - Nov. 14, 2017

Securities to be offered to employees in employee benefit plans - Nov. 14, 2017

Opexa Therapeutics Just Filed Its Quarterly Report: Basic net loss per s... - Nov. 13, 2017

Opexa Therapeutics insider just declared ownership of no shares of Opexa Therapeutics - Oct. 6, 2017

Opexa Therapeutics insider was just granted 6,000 options - Oct. 6, 2017

Opexa Therapeutics insider was just granted 9,000 options - Oct. 6, 2017

Opexa Therapeutics insider was just granted 6,000 options - Oct. 6, 2017

Opexa Therapeutics insider was just granted 9,000 options - Oct. 6, 2017

Opexa Therapeutics insider was just granted 100,000 options - Oct. 6, 2017

Opexa Therapeutics insider was just granted 46,000 options - Oct. 6, 2017

Opexa Therapeutics insider was just granted 67,600 options - Oct. 6, 2017

Opexa: Acer Therapeutics Appoints Dr. William T. Andrews As Chief Medical Officer - Oct. 5, 2017

Chris Schelling just provided an update on activist position in Opexa Therapeutics - Sept. 29, 2017

Christopher R. Manning just provided an update on activist position in Opexa Therapeutics - Sept. 28, 2017

Major owner of Opexa Therapeutics just declared owning 2,063,976 shares of Opexa Therapeutics - Sept. 27, 2017

Major owner of Opexa Therapeutics just picked up 2,063,976 shares - Sept. 27, 2017

Regulation FD - Sept. 26, 2017

Opexa Therapeutics insider just picked up 11,905 shares - Sept. 21, 2017

Opexa Therapeutics insider just picked up 125,000 shares - Sept. 21, 2017

Opexa Therapeutics insider was just granted 40,000 options - Sept. 21, 2017

Opexa Therapeutics insider just picked up 5,952 shares - Sept. 21, 2017

Opexa Therapeutics insider just picked up 1,750,000 shares - Sept. 21, 2017

Opexa Therapeutics insider just declared ownership of no shares of Opexa Therapeutics - Sept. 21, 2017

Opexa Therapeutics insider just declared ownership of no shares of Opexa Therapeutics - Sept. 21, 2017

Opexa Therapeutics insider just declared ownership of no shares of Opexa Therapeutics - Sept. 21, 2017

Opexa Therapeutics insider just declared ownership of no shares of Opexa Therapeutics - Sept. 21, 2017

Opexa Therapeutics insider just declared ownership of no shares of Opexa Therapeutics - Sept. 21, 2017

Opexa Therapeutics insider just declared ownership of no shares of Opexa Therapeutics - Sept. 21, 2017

Opexa Therapeutics insider just declared ownership of no shares of Opexa Therapeutics - Sept. 21, 2017

Opexa: Press Release Issued By The Registrant On September 19, 2017 Blueprint - Sept. 20, 2017

Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Opexa Therapeutics - Sept. 11, 2017

Opexa: Form, Schedule Or Registration Statement No Filing Party: Date Filed: Dear Shareholders, - Sept. 1, 2017

Opexa Therapeutics Just Filed Its Quarterly Report: The accompanying int... - Aug. 14, 2017

Opexa Therapeutics Reports Second Quarter 2017 Financial Results And Provides Corporate Update - Aug. 14, 2017

Opexa Therapeutics just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 11, 2017

Opexa Therapeutics Just Received a Notice of Effectiveness - Aug. 10, 2017

Opexa Therapeutics Sets Date For Special Meeting Of Shareholders - Aug. 9, 2017

Registration of securities, business combinations - Aug. 8, 2017

Confidential treatment order - Aug. 4, 2017

Registration of securities, business combinations - July 19, 2017

Current report, item 8.01 - July 19, 2017

Prospectuses and communications, business combinations - July 3, 2017

Acer Therapeutics And Opexa Therapeutics Sign Merger Agreement - July 3, 2017

Notice of Delisting or Failure to Satisfy Continued Listing Rule or - May 22, 2017

Notice of Delisting or Failure to Satisfy Continued Listing Rule or - April 14, 2017

Press Release Issued By Opexa Therapeutics, Inc. On March 28, 2017 Blueprint - March 28, 2017

Opexa Facility Becomes Foundation For Contract Manufacturing And - Feb. 1, 2017

Randa Duncan Williams just provided an update on activist position in Opexa Therapeutics - Dec. 8, 2016

Termination of a Material Definitive - Nov. 25, 2016

Opexa Therapeutics director just disposed of 14,914 shares - Nov. 22, 2016

Opexa Therapeutics Just Filed Its Quarterly Report: Results of Phase IIb... - Nov. 14, 2016

Opexa Therapeutics Reports Third Quarter 2016 Financial Results And Provides Corporate Update - Nov. 14, 2016

Opexa Announces Reduction In Workforce In Light Of Top-Line Results From Phase 2B Abili-T Trial Of Tcelna® ( - Nov. 2, 2016

Opexa Therapeutics Announces Phase 2B Abili-T Trial Of Tcelna® ( - Oct. 28, 2016

Opexa Therapeutics director just picked up 6,455 shares - Oct. 4, 2016

Opexa Therapeutics director just picked up 6,455 shares - Oct. 4, 2016

Opexa Therapeutics director just picked up 6,455 shares - Oct. 4, 2016

Opexa Therapeutics director just picked up 6,455 shares - Oct. 4, 2016

Regulation FD - Sept. 12, 2016

Securities to be offered to employees in employee benefit plans - Aug. 11, 2016

Opexa Therapeutics Just Filed Its Quarterly Report: On July 29, 2016, th... - Aug. 11, 2016

Opexa Therapeutics Reports Second Quarter 2016 Financial Results And Provides Corporate Update - Aug. 11, 2016

Opexa Therapeutics director just picked up 6,455 shares - July 1, 2016

Opexa Therapeutics director just picked up 6,455 shares - July 1, 2016

Opexa Therapeutics director just picked up 6,455 shares - July 1, 2016

Opexa Therapeutics director just picked up 6,455 shares - July 1, 2016

Opexa Therapeutics's Chief Scientific Officer was just granted 50,000 options - May 18, 2016

Submission of Matters to a Vote of Security - May 18, 2016

Opexa Therapeutics director just picked up 6,455 shares - May 18, 2016

President of Opexa Therapeutics was just granted 50,000 options - May 18, 2016

Opexa Therapeutics director just picked up 6,455 shares - May 18, 2016

Opexa Therapeutics director just picked up 6,455 shares - May 18, 2016

Opexa Therapeutics's Chief Development Officer was just granted 50,000 options - May 18, 2016

Opexa Therapeutics director just picked up 6,455 shares - May 18, 2016

Opexa Therapeutics Just Filed Its Quarterly Report: The accompanying int... - May 12, 2016

Opexa Therapeutics Reports First Quarter 2016 Financial Results And Provides Corporate Update - May 12, 2016

Opexa Therapeutics releases salary data. CEO sees compensation fall -71% - April 11, 2016

Opexa Therapeutics Just Received a Notice of Effectiveness - March 25, 2016

Entry into a Material Definitive - March 25, 2016

Opexa Therapeutics just filed a prospectus, suggesting it plans to soon issue some securities - March 25, 2016

Registration statement under Securities Act of 1933 - March 18, 2016

Opexa Therapeutics Reports 2015 Year End Financial Results And Provides Corporate Update - March 15, 2016

Opexa Therapeutics Just Filed Its Annual Report: On March 2, 2016, th... - March 15, 2016

Opexa Launches Restructuring Initiative To Focus Use Of Resources Ahead Of Key Phase 2 Data Expected In Early Q4 2016 - March 2, 2016

Moez Kassam just provided an update on share ownership of Opexa Therapeutics - Feb. 5, 2016

Opexa Therapeutics director just picked up 1,354 shares - Jan. 4, 2016

Opexa Therapeutics director just picked up 1,354 shares - Jan. 4, 2016

Opexa Therapeutics director just picked up 1,354 shares - Jan. 4, 2016

Registration statement under Securities Act of 1933 - Dec. 2, 2015

Current report, items 2.02, 7.01, 8.01, and 9.01 - Nov. 10, 2015

Opexa Therapeutics's Chief Scientific Officer just declared owning 4,045 shares of Opexa Therapeutics - Nov. 3, 2015

Opexa Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Listing Requirement - Oct. 15, 2015

Opexa Therapeutics director just picked up 1,200 shares - Oct. 2, 2015

Opexa Therapeutics director just picked up 1,200 shares - Oct. 2, 2015

Opexa Therapeutics director just picked up 1,200 shares - Oct. 2, 2015

Opexa Announces Reverse Stock Split - Sept. 28, 2015

Opexa: Submission Of Matters To A Vote Of Security Holders - Sept. 3, 2015

Opexa Therapeutics, Inc. Investor Presentation, September 2015 - Sept. 2, 2015

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. KCG Holdings, Inc. 737,736 N/A June 30, 2017
2. Bank of New York Mellon Corp 69,798 N/A June 30, 2017
3. Geduld E E 60,200 N/A Dec. 31, 2016
4. MORGAN STANLEY 38,043 N/A Dec. 31, 2016
5. Moez Kassam 19,676 N/A Dec. 31, 2015
6. BlackRock Fund Advisors 1,946 N/A Sept. 30, 2016

Opexa Therapeutics (OPXA)

140
 


Feedback